CSE/RUU (CSE/RUU)

Canadian Securities Exchange: CSE/RUU · CAD

CA$0.16

+0.01 (+3.2%)· Recorded snapshot

Market cap	8.8M
Net income (ttm)	-3.2M
EPS (ttm)	-CA$0.07
Shares out	54.8M
Volume	6,500
Beta	2.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -3.2M
EPS (ttm): -CA$0.07
Market cap: 8.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-1,457.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CSE/RUU indicators

Market & fundamental data

Available fields

147

Groups with data

Currency

CAD

Showing 147 of 147 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-10-30
Enterprise value	CAD 8.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2013
Industry	Pharmaceutical Preparations
Is primary listing	Yes
ISIN number	CA75867L2066
Last earnings date	2026-01-30
Last refreshed	2026-10-29
Last stock split date	2024-02-15
Last stock split type	Reverse
Market cap	CAD 8.8M
Next earnings date	2026-10-30
Price	CAD 0.16
Price currency	CAD
SIC code	2834
Stock price date	2026-10-28
Symbol	cse/RUU
Website	https://refinedenergy.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-43.28%
FCF / EV yield	-45.33%
FCF yield	-42.64%
P/B ratio	25.15x
Price / tangible book value	25.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-340.83%
ROA (5Y)	-160.83%
ROCE	-1,073.31%
ROIC	-1,457.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	178.08%
Net income growth (Q)	289.43%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -2,019
Depreciation and amortization	CAD 475,785
EBIT	CAD -3.7M
EBITDA	CAD -3.3M
EPS	CAD -0.07
FCF per share	CAD -0.07
Financing cash flow	CAD 4.4M
Free cash flow	CAD -3.7M
Free cash flow minus SBC	CAD -3.7M
Investing cash flow	CAD -2,019
Net cash flow	CAD 689,010
Net income	CAD -3.2M
Operating cash flow minus SBC	CAD -3.7M
Operating income	CAD -3.7M
Stock-based compensation	CAD 3,545

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	CAD 0.01
Debt / equity	0.58
Interest coverage	-204.91
Long-term assets	CAD 0
Long-term liabilities	CAD 0
Net cash (debt)	CAD 519,461
Net cash / market cap	5.93%
Net debt / equity	-1.49
Piotroski F-Score	0
Shareholders' equity	CAD 348,530
Tangible book value	CAD 348,530
Tangible book value per share	CAD 0.01
Total assets	CAD 957,815
Total cash	CAD 721,954
Total debt	CAD 202,493
Total liabilities	CAD 609,285
WACC	15.53%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 957,815
Current liabilities	CAD 609,285
Current ratio	1.57
Net working capital	CAD -170,931
Quick ratio	1.54
Working capital	CAD 348,530

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-31.38%
Shareholder yield	-31.38%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.28
1D price change	3.23%
1M price change	-8.57%
1M total return	-8.57%
1W price change	-5.88%
1W total return	-5.88%
1Y price change	-15.79%
1Y return CAGR	-15.8%
1Y total return	-15.79%
20-day SMA	CAD 0.17
200-day SMA	CAD 0.38
3M price change	-11.11%
3M total return	-11.11%
3Y price change	-5.88%
3Y return CAGR	-2%
3Y total return	-5.88%
50-day SMA	CAD 0.19
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 1.12
52-week high date	2026-01-19
52-week low	CAD 0.16
52-week low date	2026-10-26
5Y price change	-72.41%
5Y return CAGR	-22.71%
5Y total return	-72.41%
6M price change	-61.45%
6M total return	-61.45%
All-time high	CAD 91.20
All-time high date	2019-03-11
All-time low	CAD 0.06
All-time low date	2024-03-25
Average true range (ATR)	CAD 0.01
Average volume	10.1K
Beta (1Y)	1.57
Beta (2Y)	1.84
Beta (5Y)	2.09
Change from 52-week high	-85.71%
Change from 52-week low	3.23%
Change from all-time high	-99.82%
Change from all-time low	166.67%
Change from open	0%
Day's gap	3.23%
Dollar volume	CAD 1,040
High price	CAD 0.16
Low price	CAD 0.16
Monthly RSI	41.32
Open price	CAD 0.16
Previous close	CAD 0.16
Price vs 150-day SMA	-43.5%
Price vs 20-day SMA	-7.94%
Price vs 200-day SMA	-58.12%
Price vs 50-day SMA	-15.57%
Relative volume	0.64
RSI	40.28
Sharpe ratio	0.39
Sharpe ratio (3Y)	0.66
Sharpe ratio (5Y)	0.45
Sortino ratio	0.68
Sortino ratio (3Y)	1.19
Sortino ratio (5Y)	0.8
Volume	6.5K
Weekly RSI	33.71
YTD price change	-70.37%
YTD total return	-70.37%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49.7M
Shares change (QoQ)	-8.87%
Shares change (YoY)	31.38%
Shares held by insiders	9.24%
Shares held by institutions	0%
Shares outstanding	54.8M

Deeper analysis on CSE/RUU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/RUU report

Is a complete CSE/RUU research report available?

No complete published report is available for cse/RUU (CSE/RUU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/RUU (CSE/RUU)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/RUU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/RUU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CSE/RUU

Frequently asked questions